U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H16N2O.C6H6O4.Pt
Molecular Weight 481.408
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENLOPLATIN

SMILES

[Pt++].NCC1(CN)CCOCC1.[O-]C(=O)C2(CCC2)C([O-])=O

InChI

InChIKey=ASQRQYODAQUVBR-UHFFFAOYSA-L
InChI=1S/C7H16N2O.C6H8O4.Pt/c8-5-7(6-9)1-3-10-4-2-7;7-4(8)6(5(9)10)2-1-3-6;/h1-6,8-9H2;1-3H2,(H,7,8)(H,9,10);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C7H16N2O
Molecular Weight 144.2147
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C6H6O4
Molecular Weight 142.1094
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Pt
Molecular Weight 195.084
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Enloplatin (CL 287110) is a platinum complex with antineoplastic properties. It is more water soluble than cisplatin. Enloplatin was developing by Wyeth-Lederle for the treatment of patients with ovarian cancer and leukemia.

Approval Year

PubMed

PubMed

TitleDatePubMed
CL 287,110 and CL 286,558.
1989
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma.
1997 Aug

Sample Use Guides

Phase I trial: 83-375mg/m2
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:51:03 GMT 2023
Edited
by admin
on Sat Dec 16 17:51:03 GMT 2023
Record UNII
C7HT2IO79H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENLOPLATIN
INN   MART.   USAN  
USAN   INN  
Official Name English
ENLOPLATIN [MART.]
Common Name English
PLATINUM, (1,1-CYCLOBUTANEDICARBOXYLATO(2-))(TETRAHYDRO-4H-PYRAN-4,4-DIMETHANAMINE-N,N')-, (SP-4-2)-
Common Name English
enloplatin [INN]
Common Name English
cis-(1,1-Cyclobutanedicarboxylato)[tetrahydro-4H-pyran-4,4-bis(methylamine)]platinum
Common Name English
CL-287110
Code English
ENLOPLATIN [USAN]
Common Name English
CL 287,110
Code English
Classification Tree Code System Code
NCI_THESAURUS C1450
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C95323
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
FDA UNII
C7HT2IO79H
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
PUBCHEM
68737
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
CAS
111523-41-2
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
INN
6668
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
EPA CompTox
DTXSID80912197
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
USAN
CC-4
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
SMS_ID
100000080232
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
EVMPD
SUB06536MIG
Created by admin on Sat Dec 16 17:51:03 GMT 2023 , Edited by admin on Sat Dec 16 17:51:03 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY